questionsmedicales.fr
Structures virales
Virion
Virion : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virion : Questions médicales les plus fréquentes",
"headline": "Virion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-12",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures virales",
"url": "https://questionsmedicales.fr/mesh/D056224",
"about": {
"@type": "MedicalCondition",
"name": "Structures virales",
"code": {
"@type": "MedicalCode",
"code": "D056224",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nucléocapside",
"alternateName": "Nucleocapsid",
"url": "https://questionsmedicales.fr/mesh/D019251",
"about": {
"@type": "MedicalCondition",
"name": "Nucléocapside",
"code": {
"@type": "MedicalCode",
"code": "D019251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Capside",
"alternateName": "Capsid",
"url": "https://questionsmedicales.fr/mesh/D002213",
"about": {
"@type": "MedicalCondition",
"name": "Capside",
"code": {
"@type": "MedicalCode",
"code": "D002213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Enveloppe virale",
"alternateName": "Viral Envelope",
"url": "https://questionsmedicales.fr/mesh/D000086942",
"about": {
"@type": "MedicalCondition",
"name": "Enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D000086942",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virion",
"alternateName": "Virion",
"code": {
"@type": "MedicalCode",
"code": "D014771",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tibor Füzik",
"url": "https://questionsmedicales.fr/author/Tibor%20F%C3%BCzik",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Pavel Plevka",
"url": "https://questionsmedicales.fr/author/Pavel%20Plevka",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz."
}
},
{
"@type": "Person",
"name": "Liya Mukhamedova",
"url": "https://questionsmedicales.fr/author/Liya%20Mukhamedova",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Antonín Přidal",
"url": "https://questionsmedicales.fr/author/Anton%C3%ADn%20P%C5%99idal",
"affiliation": {
"@type": "Organization",
"name": "Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Michael Way",
"url": "https://questionsmedicales.fr/author/Michael%20Way",
"affiliation": {
"@type": "Organization",
"name": "Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Determination of the UV Inactivation Constant Under 280 nm UV LED Irradiation for SARS-CoV-2.",
"datePublished": "2022-06-17",
"url": "https://questionsmedicales.fr/article/35578782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/php.13653"
}
},
{
"@type": "ScholarlyArticle",
"name": "Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2).",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36366517",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v14112419"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aerosolized Hydrogen Peroxide Decontamination of N95 Respirators, with Fit-Testing and Viral Inactivation, Demonstrates Feasibility for Reuse during the COVID-19 Pandemic.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36040048",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/msphere.00303-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.",
"datePublished": "2023-01-08",
"url": "https://questionsmedicales.fr/article/36573801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17238"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enveloped and non-enveloped virus survival on microfiber towels.",
"datePublished": "2023-04-13",
"url": "https://questionsmedicales.fr/article/37073274",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15202"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures virales",
"item": "https://questionsmedicales.fr/mesh/D056224"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virion",
"item": "https://questionsmedicales.fr/mesh/D014771"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virion",
"description": "Comment identifier un virion dans un échantillon ?\nQuels tests sont utilisés pour détecter les virions ?\nLes virions peuvent-ils être visualisés au microscope ?\nQuelle est la méthode de culture des virions ?\nLes tests sérologiques détectent-ils les virions ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virion",
"description": "Quels symptômes indiquent une infection virale ?\nLes virions causent-ils toujours des symptômes ?\nComment les symptômes varient-ils selon le virion ?\nLes symptômes d'une infection virale sont-ils immédiats ?\nLes virions peuvent-ils provoquer des symptômes neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virion",
"description": "Comment prévenir les infections virales ?\nLes masques protègent-ils contre les virions ?\nLes vaccins sont-ils efficaces contre tous les virions ?\nL'hygiène personnelle aide-t-elle à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virion",
"description": "Quels traitements sont efficaces contre les virions ?\nLes antibiotiques sont-ils efficaces contre les virions ?\nComment les vaccins agissent-ils contre les virions ?\nLes traitements symptomatiques sont-ils utiles ?\nLes traitements antiviraux sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virion",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes virions peuvent-ils causer des maladies chroniques ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le virion ?\nLes enfants sont-ils plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virion",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe stress affecte-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nL'environnement joue-t-il un rôle dans le risque viral ?\nLes habitudes alimentaires influencent-elles le risque viral ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Virus+Inactivation&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un virion dans un échantillon ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par microscopie électronique ou tests PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virions ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR, les cultures virales et les tests sérologiques sont courants."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils être visualisés au microscope ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les virions peuvent être visualisés au microscope électronique."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de culture des virions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les virions sont cultivés dans des cellules hôtes appropriées en laboratoire."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques détectent-ils les virions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils détectent les anticorps contre les virions, pas les virions eux-mêmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont fréquents."
}
},
{
"@type": "Question",
"name": "Les virions causent-ils toujours des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virions peuvent être asymptomatiques chez l'hôte."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon le virion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de virus et de l'hôte infecté."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils immédiats ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut y avoir une période d'incubation avant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils provoquer des symptômes neurologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme ceux de la grippe, peuvent affecter le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virions par voie respiratoire."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virions ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virions spécifiques et ne protège pas contre tous."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle aide-t-elle à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle réduit le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virions et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les virions ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, comme l'oseltamivir, sont utilisés pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les vaccins agissent-ils contre les virions ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins stimulent le système immunitaire à reconnaître et combattre les virions."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à soulager les symptômes, mais ne traitent pas l'infection virale."
}
},
{
"@type": "Question",
"name": "Les traitements antiviraux sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité dépend du type de virus et de la résistance virale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la déshydratation ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme le VIH, peuvent entraîner des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des traitements symptomatiques et des soins médicaux appropriés."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virion peut entraîner des complications différentes selon l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux complications des infections virales."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le système immunitaire affaibli et l'exposition à des porteurs."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir l'immunité et augmenter le risque d'infection virale."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans le risque viral ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque viral ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
The ongoing emergency provoked by the SARS-CoV-2 pandemic demands the development of technologies to mitigate the spread of infection, and UV irradiation is a technique that can efficiently address th...
Therapeutic blood products including convalescent plasma/serum and immunoglobulins concentrated from convalescent plasma, such as intravenous immunoglobulins or hyperimmune globulins, and monoclonal a...
In response to the demand for N95 respirators by health care workers during the COVID-19 pandemic, we evaluated decontamination of N95 respirators using an aerosolized hydrogen peroxide (aHP) system. ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unlikely to be a major transfusion-transmitted pathogen; however, convalescent plasma is a treatment option used in some regions. The ri...
SARS-CoV-2 spiked plasma units were treated using the THERAFLEX MB-Plasma system in the presence of methylene blue (~0.8 μmol/L; visible light doses: 20, 40, 60, and 120 [standard] J/cm...
Treatment of spiked plasma with the THERAFLEX MB-Plasma system resulted in an average ≥5.03 log...
SARS-CoV-2 infectivity was reduced in plasma and platelets following treatment with the THERAFLEX MB-Plasma and THERAFLEX UV-Platelets systems, to the limit of detection, respectively. These PI techno...
Handwashing is an important intervention which can reduce indirect disease transmission, however soap and water for handwashing purposes is not available in some low-resource regions. When handwashing...
We seeded the Supertowel and a regular microfiber towel with two bacteriophages (enveloped Phi6 and non-enveloped MS2) and monitored viral inactivation over time. Additionally, we assessed if temperat...
We found that neither towel type (whether the towel was a Supertowel or a regular microfiber towel) nor humidity were significant variables in our model of decay rate constants (...
Viruses seeded onto a Supertowel decay similar to viruses seeded onto a regular towel indicating that the virucidal potential of the Supertowel is minimal....
Covid-19 has spurred a renewed interest in decontamination techniques for air, objects and surfaces. Beginning in 2020, urgent effort was done to permit the reuse of UV-C for inactivating SARS-CoV-2. ...
Nowadays, in parallel to the appearance of the COVID-19 virus, the risk of viruses in water increases leading to the necessity of developing novel disinfection methods. This review focuses on the rout...
Different kinds of media spiked with monkeypox virus (MPXV) were subjected to heat inactivation at different temperatures for various periods of time. The results showed that MPXV was inactivated in l...
Although conventional polymerase chain reaction (PCR) methods are widely used in diagnosis, the titer of the pathogenic virus is difficult to determine based on the PCR. In our prior report, a long-ra...
IAV was inactivated by: heating at 100 °C for periods ranging from 1 to 15 min, treating with 0.12% sodium hypochlorite for periods ranging from 3 to 30 min, or treating with 70% ethanol for periods r...
One minute heating, 3 min sodium hypochlorite treatment, or 10 min ethanol treatment was sufficient to deactivate IAV. Changes before and after the inactivations in the copy numbers on LR-RT-qPCR were...
In addition to good applicability in UV-irradiation previously reported, the LR-RT-qPCR method is suitable for evaluating the effect of heat-inactivation on IAV infectivity. However, minor modificatio...
Chitosan films were prepared by solvent casting using an acetic acid-based solution. The films that were developed contained 15.49% of acetic acid solution (10%...